LLC AG Aspect (Scientific consultant)
LLC «RDE «Astrapharm» (Scientific consultant)
Russian Federation
LLC «AG «Aspect» (Veterinarian)
LLC «RDE «Astrapharm» (Leading veterinarian)
LLC «BioFeron» (Leading veterinarian)
employee
Russian Federation
employee
Russian Federation
LLC «RDE «Astrapharm» (Chief science specialist)
LLC «BioFeron» (Chief science specialist)
employee
Russian Federation
68.41
During toxicological assessment, it was established that the absolute (LD100) and median (LD50) lethal doses of the medicinal product Trazapentin® tablets for cats were not determined. According to GOST 12.1.007-76 «Harmful Substances. Classification and General Safety Requirements», the drug was classified as Hazard Class IV «Slightly Hazardous Substances». A study of chronic toxicity of Trazapentin® tablets for cats with its daily oral administration to rats for 90 days at all tested doses showed no animal mortality and no negative impact on the animal body, both during administration and after discontinuation. Trazapentin® tablets for cats do not possess allergenic or irritant properties in provocative skin and conjunctival tests.
Trazapentine®, succinate trazodone, trazodone, gabapentin, acute toxicity, chronic toxicity, allergenic properties
1. Beloglazov, D.V. Ocenka effektivnosti novogo preparata Ekspress Uspokoin® tabletki pri situacionnoy korrekcii povedencheskih problem u koshek / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2023. – № 2. – S. 14-22. – DOIhttps://doi.org/10.32416/2500-4379-2023-2-14-22.
2. Beloglazov, D.V. Ocenka effektivnosti novogo preparata «Ekspress Uspokoin® tabletki» pri situacionnoy korrekcii povedencheskih problem u sobak / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Sovremennaya veterinarnaya medicina. – 2023. ‒ № 1. ‒ C. 18-22.
3. Elizarova, E.A. Ocenka effektivnosti novogo lekarstvennogo preparata Kurs Uspokoin tabletki dlya korrekcii vozrastnyh kognitivnyh narusheniy u koshek / E.A. Elizarova, D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2024. – № 3. – S. 27-33. – DOIhttps://doi.org/10.32416/2500-4379-2024-3-27-33.
4. Beloglazov, D.V. Trazodona sukcinat ‒ novye vozmozhnosti farmakologicheskoy korrekcii situacionnyh povedencheskih otkloneniy u sobak i koshek / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2021. – № 4. – S. 5-13. – DOIhttps://doi.org/10.32416/2500-4379-2021-4-5-13.
5. Kurs Uspokoin tabletki. Instrukciya po veterinarnomu primeneniyu lekarstvennogo preparata [Elektronnyy resurs]. https://galen.vetrf.ru/files/5c1ac33d-9461-4add-bd1c-e04b2d82f1fb (data obrascheniya 21.01.25).
6. Prikaz Ministerstva sel'skogo hozyaystva RF №101 ot 06.03.2018 g. «Ob utverzhdenii Pravil provedeniya doklinicheskogo issledovaniya lekarstvennogo sredstva dlya veterinarnogo primeneniya, klinicheskogo issledovaniya lekarstvennogo preparata dlya veterinarnogo primeneniya, issledovaniya bioekvivalentnosti lekarstvennogo preparata dlya veterinarnogo primeneniya». Zaregistrirovan v Minyuste Rossii 05.06.2018 № 51296.
7. Rukovodstvo po provedeniyu doklinicheskih issledovaniy lekarstvennyh sredstv. Chast' pervaya / A.N. Mironov, N.D. Bunatyan i dr. – M.: Grif i K, 2012. – 944 s.
8. Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novyh farmakologicheskih veschestv / Pod red. R. U. Habrieva. – M.: Medicina, 2005. – 832s.
9. Smirnov, A.V. Yantarnaya kislota i ee primenenie v medicine. Chast' I. Yantarnaya kislota: metabolit i regulyator metabolizma organizma cheloveka / A.V. Smirnov, O.B. Nesterova, R.V. Golubev // Nefrologiya. – 2014. – T. 18. – № 2. – S. 33-41.
10. Ekspress Uspokoin® tabletki. Instrukciya po veterinarnomu primeneniyu lekarstvennogo preparata [Elektronnyy resurs]. https://galen.vetrf.ru/files/41fc97ef-69b3-4502-bded-57bb87220cd6 (data obrascheniya 21.01.25).
11. Adrian, D.E. Prescribing practices of veterinarians in the treatment of chronic musculoskeletal pain in cats / D.E. Adrian, M. Rishniw, M. Scherk, et al. // J Feline Med Surg. ‒ 2019 Jun. ‒ No. 21 (6). ‒ hh. 495-506. doi:https://doi.org/10.1177/1098612X18787910.
12. Boyle, Y. The effect of a combination of gabapentin and donepezil in an experimental pain model in healthy volunteers: Results of a randomized controlled trial / Y. Boyle, D. Fernando, H. Kurz, S.R. Miller, M. Zucchetto, J. Storey // Pain. ‒ 2014. ‒ No. 155(12). ‒ pp. 2510-2516. doihttps://doi.org/10.1016/j.pain.2014.09.003.
13. Cheng, H.F. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors / H.F. Cheng, R.C. Harris // Curr Pharm Des. ‒ 2005. ‒ No. 11(14). ‒ pp. 1795-1804. doihttps://doi.org/10.2174/1381612053764922.
14. Chincholkar, M. Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review / M. Chincholkar // Br J Anaesth. ‒ 2018. ‒ No. 120(6). ‒ pp. 1315-1334. doihttps://doi.org/10.1016/j.bja.2018.02.066.
15. Edwards, R.R. Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis / R.R. Edwards, A.J. Dolman, M.O. Martel, et al. // BMC Musculoskelet Disord. ‒ 2016. ‒ No. 17. ‒ pp. 284. Published 2016 Jul 13. doihttps://doi.org/10.1186/s12891-016-1124-6.
16. Enomoto M., Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats / M. Enomoto, P.W. Mantyh, J. Murrell, J.F. Innes, B.D.X. Lascelles // Vet Rec. ‒ 2019. ‒ No. 184(1). ‒ pp. 23. doihttps://doi.org/10.1136/vr.104590.
17. Garrone, B. Synergistic interaction between trazodone and gabapentin in rodent models of neuropathic pain / B. Garrone // PLoS One. ‒ 2021. ‒ No. 16(1). ‒ e0244649.
18. Garry, E.M. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs / E.M. Garry, A. Delaney, H.A. Anderson, et al. // Pain. ‒ 2005. ‒ No. 118 (1-2). ‒ pp. 97-111. doihttps://doi.org/10.1016/j.pain.2005.08.003.
19. Gilron, I. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial / J.M. Bailey, D. Tu, R.R. Holden, A.C. Jackson, R.L. Houlden // Lancet. ‒ 2009. ‒ No. 374(9697). ‒ pp. 1252-1261. doihttps://doi.org/10.1016/S0140-6736(09)61081-3.
20. Godfrey, D.R. Osteoarthritis in cats: a retrospective radiological study / D.R. Godfrey // J Small Anim Pract. ‒ 2005. ‒ No. 46(9). ‒ pp. 425-429. doihttps://doi.org/10.1111/j.1748-5827.2005.tb00340.x
21. Gruen, M.E. Detection of clinically relevant pain relief in cats with degenerative joint disease associated pain / M.E. Gruen, E. Griffith, A. Thomson, et al. // J Vet Intern Med. ‒ 2014. ‒No. 28(2). ‒ pp. 346-350.
22. Gruen, M.E. AAHA Pain Management Guidelines for Dogs and Cats. / M.E. Gruen, B.D.X. Lascelles, E. Colleran, et al. // J Am Anim Hosp Assoc. ‒ 2022. ‒ No. 58(2). ‒ pp. 55-76. doihttps://doi.org/10.5326/JAAHA-MS-7292.
23. Gruen, M.E. A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study. / M.E. Gruen, A.E. Thomson, E.H. Griffith, H. Paradise, D.P. Gearing, // J Vet Intern Med. ‒ 2016. ‒ No. 30(4). ‒ pp. 1138-1148. doihttps://doi.org/10.1111/jvim.13972.
24. Guedes, A.G.P. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impirment and quality of life in osteoarthritic geriatric cats / A.G.P. Guedes, J.M. Meadows, B.H. Pypendop, et al. // J Am Vet Med Assoc. ‒ 2018. ‒ No. 253(5). ‒ pp. 579-85.
25. Hardie, E.M. Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994-1997) / E.M. Hardie, S.C. Roe, F.R. Martin // J Am Vet Med Assoc. ‒ 2002. ‒ No. 220(5). ‒ pp. 628-632. doihttps://doi.org/10.2460/javma.2002.220.628
26. Heughan, C.E. The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration / C.E. Heughan, J. Sawynok // Anesth Analg. ‒ 2002. ‒ No. 94(4). ‒ pp. 975-980. doihttps://doi.org/10.1097/00000539-200204000-00037.
27. Liu, V.W.C. Antidepressants for the Treatment of Neuropathic Pain / V.W.C. Liu, L.W. Lam, H.F.K. Chiu // Hong Kong J Psychiatry. ‒ 2002. ‒ No. 12(4). ‒ pp. 23-27.
28. Lascelles B.D.X. Management of chronic cancer pain / B.D.X. Lascelles. In: Withrow S, Vail D, Page R. (eds). Small animal clinical oncology. St Louis, MO: Elsevier, 2013, pp 245-259.
29. Martell-Moran, N.K. Pain and adverse behavior in declawed cats / N.K. Martell-Moran, M. Solano, H.G. Townsend // J Feline Med Surg. ‒ 2018. ‒ No. 20(4). ‒ pp. 280-288. doihttps://doi.org/10.1177/1098612X1770504.
30. Mizisin, A.P. Neurological complications associated with spontaneously occurring feline diabetes mellitus / A.P. Mizisin, G.D. Shelton, M.L. Burgers, H.C. Powell, P.A. Cuddon // J Neuropathol Exp Neurol. ‒ 2002. ‒ No. 61(10). ‒ pp. 872-884. doihttps://doi.org/10.1093/jnen/61.10.872.
31. Monteiro, B.P. Chronic pain in cats: Recent advances in clinical assessment / B.P. Monteiro, P.V. Steagall // J Feline Med Surg. ‒ 2019. ‒ No. 21(7). ‒ pp. 601-614. doihttps://doi.org/10.1177/1098612X19856179
32. Muthuraman, A. Drug therapy of neuropathic pain: current developments and future perspectives / A. Muthuraman, N. Singh, A.S. Jaggi, M. Ramesh // Curr Drug Targets. ‒ 2014. ‒ No. 15(2). ‒ pp. 210-253.
33. Oggianu, L. PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK-PD modeling from nonclinical to clinical development / L. Oggianu, B. Garrone, F. Fiorentini, et al. // Clin Transl Sci. ‒ 2023. ‒ No. 16(4). ‒ pp. 606-617. doihttps://doi.org/10.1111/cts.13472.
34. Okuda, K. Trazodone hydrochloride attenuates thermal hyperalgesia in a chronic constriction injury rat model / K. Okuda, T. Takanishi, K. Yoshimoto, S. Ueda // Eur J Anaesthesiol. ‒ 2003. ‒ No. 20(5). ‒ pp. 409-415. doihttps://doi.org/10.1017/s0265021503000632.
35. Patel, R. Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain / R. Patel, A.H. Dickenson // Pharmacol Res Perspect. ‒ 2016. ‒ No. 4(2). ‒ e00205. Published 2016 Feb 27. doihttps://doi.org/10.1002/prp2.205.
36. Petrere, J.A. Developmental toxicity studies in mice, rats, and rabbits with the anticonvulsant gabapentin / J.A. Petrere, J.A. Anderson // Fundam Appl Toxicol. ‒ 1994. ‒ No. 23(4). ‒ pp. 585-589. doihttps://doi.org/10.1006/faat.1994.1144.
37. Slingerland, L.I. Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats / L.I. Slingerland, H.A. Hazewinkel, B.P. Meij, P. Picavet, G. Voorhout // Vet J. ‒ 2011. ‒ No. 187(3). ‒ pp. 304-309. doihttps://doi.org/10.1016/j.tvjl.2009.12.014.
38. Sparkes, A.H. ISFM consensus guidelines on the practical management of diabetes mellitus in cats / A.H. Sparkes, M. Cannon, D. Church, et al. // J Feline Med Surg. ‒ 2015. ‒ No. 17(3). ‒ pp. 235-250. doihttps://doi.org/10.1177/1098612X15571880.
39. Stahl, S.M. Mechanism of action of trazodone: a multifunctional drug / S.M. Stahl // CNS Spectr. ‒ 2009. ‒ No. 14(10). ‒ pp. 536-546. doihttps://doi.org/10.1017/s1092852900024020.
40. Steagall, P.V. Multimodal analgesia for perioperative pain in three cats / P.V. Steagall, B.P. Monteiro-Steagall // J Feline Med Surg. ‒ 2013. ‒ No. 15(8). ‒ pp. 737-743. doihttps://doi.org/10.1177/1098612X13476033.
41. Taylor, C.P. Mechanisms of action of gabapentin / C.P. Taylor // Rev Neurol (Paris). ‒ 1997. ‒ No. 153 Suppl 1. ‒ S39-S45.
42. Vasudevan, R. Alleviation of neuropathic pain by trazodone in rats / R. Vasudevan // Brazilian Journal of Pharmaceutical Sciences. ‒ 2022. ‒ No. 58. ‒ e19256.
43. Walsh, K. Chronic pain management in dogs and cats / K. Walsh // In Pract. ‒ 2016. ‒ No. 38. ‒ pp. 155-65. doi:https://doi.org/10.1136/inp.i1489
44. Watanabe, R. A multidisciplinary study of pain in cats undergoing dental extractions: A prospective, blinded, clinical trial / R. Watanabe, G. Doodnaught, C. Proulx, et al. // PLoS One. ‒ 2019. ‒ No. 14(3). ‒ e0213195. Published 2019 Mar 1. doihttps://doi.org/10.1371/journal.pone.0213195.
45. Watanabe, R. Pain behaviors before and after treatment of oral disease: preliminary results / R. Watanabe, D. Frank, P. Steagall. In: Proceeding of 8th Annual Congress of Asian Society of Veterinary Surgery. Taichung, Taiwan, 2018. pp.1-11.
